Get 20% lifetime commission for referring investors to digrin.com
here.
Evommune, Inc. ( EVMN) - Stock Earnings
EVMN Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Oct. 16, 2026, midnight | — / — | — | — / — | — |
EVMN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -28.3 million USD | — USD |
| 2026Q1 | -21.7 million USD | — USD |
| 2026Q2 | -32.2 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
EVMN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -34.1 million USD | 5.0 million USD |
| 2024 | -66.8 million USD | 7.0 million USD |
| 2025 | -68.9 million USD | 13.0 million USD |
| 2026 Est. | — | — |
EVMN
Price: $5.17
52 week price:
Earnings Per Share: -11.75 USD
Exchange: NYQ
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 251.1 million